Uniseed is a venture fund that invests in innovative technologies emerging from Australian universities and research organizations.

Uniseed

Uniseed is Australia’s longest-running venture fund, operating at the Universities of Melbourne, Queensland, Sydney & New South Wales, and the CSIRO, with investment capital provided by these research organisations and investment partners including a leading Australian Superannuation Fund, UniSuper.

We are a unique commercialisation fund helping researchers from our partner research organisations turn their ideas into products and services. We support innovations that solve market problems and create a positive impact for our community. Uniseed invests over a broad range of technology sectors and has exited ten investments, to date.

QRxPharma

Smart Sparrow

Spinifex Pharmaceuticals

BT Imaging

Fibrotech Therapeutics

Fultec Semiconductor

Congratulations to Kinoxis Therapeutics Pty Ltd on the successful completion of your Series B capital raise! 

Uniseed are proud to be among the key investors supporting this important milestone, which raised an impressive $14.5 million. This funding will be instrumental in advancing your Phase 2 programs for KNX100, a groundbreaking treatment addressing the behavioral and psychological symptoms of dementia and substance use disorders. 

We look forward to witnessing the positive impact of your work, and all the great things you'll accomplish next.

John Kurek Liza Yeo Katrina Sorocos David Markwell Ross Macdonald Mary C Frey Geoff Waring Aoife Cullen Kathryn Sunn Taylor Syme Harikesh Pushpapathan Eric Xiaojia Wei Brigitte Smith

Congratulations to Hugh Alsop, CEO of Uniseed investee company Kinoxis Therapeutics Pty Ltd who won the CEO of the Year award at The Brooker Prize gala last week.

This prestigious industry award recognises Hugh's 20+ years of leadership and outstanding contributions within the Australian life sciences sector.  

Congratulations, Hugh!

Uniseed is excited to have invested in Diraq, a spin-out from UNSW developing a quantum computer to be manufactured using standard semiconductor manufacturing equipment and materials.

Colin D. Dax Kukulj David Woollard Cherie van Wensveen Leong Mar Michael Angliss Danielle Neale MBA GAICD Geoff Waring Kyle Giumelli Paul Butler Jeffrey Bourne Laura Droessler-Dansie

Congratulations to BioScout on winning the "Best in Horticulture" award at the Australian Agritech Association Awards!

Congratulations to Helen Souris and the Cardihab team on this significant achievement and partnership!

Want to find out what it takes to receive external funding to help commercialise your technology? Join Uniseed's Investment Manager Laura Droessler-Dansie for tomorrow's early-stage funding webinar!

Metric
Company Name	Uniseed
Symbol
MSH ID	COM:UNISEED
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Venture Capital
Country	AU
Stage
Employee Count	22
Website	uniseed.com
LinkedIn	uniseed
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

UNIS

COM:UNISEED

Uniseed

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue